ClearMed
AI in MedicineReal-World Cohort4 min read

A clinical multimodal vision language foundation model with fine-grain explainability

Human evaluation of these reasoning outputs using the S.C.O.R.E. framework yielded a high overall mean score of 4.25/5, supporting their clinical interpretability.

Published in Nature MedicineObservational cohort study + Clinical AI evaluation
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Real-World Observation

3/5

Prospective clinical studies are required to evaluate the safety, effectiveness and clinical utility of EVLF-FM before routine clinical deployment.

What Changes?

AI in Medicine · Real-World Cohort

Current Standard

Current limitations include the need for additional validation across diverse healthcare settings.

New Finding

A hybrid training strategy combining supervised and visual reinforcement fine-tuning enables EVLF-FM to generate clinically interpretable explanations aligned with visual evidence.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    To address this gap, we introduce Explainable Vision Language Foundation Model for Medicine (EVLF-FM), a multimodal vision language foundation model that combines broad diagnostic capabilities with fine-grained explainability.

  2. 02Study Evidence

    Tested in a observational cohort study + clinical ai evaluation at the real-world cohort stage.

  3. 03Practical Meaning

    AI model accuracy depends on training dataset diversity and requires prospective validation across independent hospitals before routine rollout.

What This Means for You

A hybrid training strategy combining supervised and visual reinforcement fine-tuning enables EVLF-FM to generate clinically interpretable explanations aligned with visual evidence. Human evaluation of these reasoning outputs using the S.C.O.R.E. framework yielded a high overall mean score of 4.25/5, supporting their clinical interpretability. Current limitations include the need for additional validation across diverse healthcare settings. Prospective clinical studies are required to evaluate the safety, effectiveness and clinical utility of EVLF-FM before routine clinical deployment.

The Discovery

Despite their considerable promise, many current medical foundation models remain modality specific and lack transparent reasoning, limiting clinical adoption. To address this gap, we introduce Explainable Vision Language Foundation Model for Medicine (EVLF-FM), a multimodal vision language foundation model that combines broad diagnostic capabilities with fine-grained explainability. The development and testing of EVLF-FM encompassed more than 1.3 million total samples from 18 global datasets across 10 imaging modalities related to six clinical specialties: dermatology, hepatology, ophthalmology, pathology, pulmonology and radiology. External validation employed 13,443 independent test samples from 17 additional datasets across 10 imaging modalities. EVLF-FM supports disease diagnosis, visual question answering and pixel-level visual grounding with reasoning capabilities. In internal validation for disease diagnostics, EVLF-FM achieved the highest average accuracy, 0.895, outperforming leading generalist and specialist models. In medical visual grounding, EVLF-FM also achieved reasonable performance across nine modalities with average accuracy at 0.5 intersection over union (Acc@0.5) of 0.842. External testing further confirmed consistent zero-shot and few-shot performance, with competitive F1 scores despite a smaller model size.

How It Works, Simply

This ai in medicine research focuses on AI model. Researchers evaluated it using an observational cohort study + Clinical AI evaluation at the real-world cohort stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    To address this gap, we introduce Explainable Vision Language Foundation Model for Medicine (EVLF-FM), a multimodal vision language foundation model that combines broad diagnostic capabilities with fine-grained explainability.

  2. 02Study Evidence

    Tested in a observational cohort study + clinical ai evaluation at the real-world cohort stage.

  3. 03Practical Meaning

    AI model accuracy depends on training dataset diversity and requires prospective validation across independent hospitals before routine rollout.

01

Biological Mechanism & Study Design

Study Design & Cohort

Observational cohort study + Clinical AI evaluation

Observational cohort study + Clinical AI evaluation · Real-World Cohort

Biological Pathway & Modality

AI model

Intervention: A clinical multimodal vision language foundation model

02

Experimental Findings & Endpoints

Despite their considerable promise, many current medical foundation models remain modality specific and lack transparent reasoning, limiting clinical adoption.

To address this gap, we introduce Explainable Vision Language Foundation Model for Medicine (EVLF-FM), a multimodal vision language foundation model that combines broad diagnostic capabilities with fine-grained explainability. The development and testing of EVLF-FM encompassed more than 1.3 million total samples from 18 global datasets across 10 imaging modalities related to six clinical specialties: dermatology, hepatology, ophthalmology, pathology, pulmonology and radiology.

External validation employed 13,443 independent test samples from 17 additional datasets across 10 imaging modalities. EVLF-FM supports disease diagnosis, visual question answering and pixel-level visual grounding with reasoning capabilities.

In internal validation for disease diagnostics, EVLF-FM achieved the highest average accuracy, 0.895, outperforming leading generalist and specialist models. In medical visual grounding, EVLF-FM also achieved reasonable performance across nine modalities with average accuracy at 0.5 intersection over union (Acc@0.5) of 0.842.

External testing further confirmed consistent zero-shot and few-shot performance, with competitive F1 scores despite a smaller model size.

03

Clinical Translation & Practice Context

A hybrid training strategy combining supervised and visual reinforcement fine-tuning enables EVLF-FM to generate clinically interpretable explanations aligned with visual evidence.

Human evaluation of these reasoning outputs using the S.C.O.R.E. framework yielded a high overall mean score of 4.25/5, supporting their clinical interpretability. Current limitations include the need for additional validation across diverse healthcare settings.

Prospective clinical studies are required to evaluate the safety, effectiveness and clinical utility of EVLF-FM before routine clinical deployment.

03

The Bottom Line · Clinical Pearl

“Prospective clinical studies are required to evaluate the safety, effectiveness and clinical utility of EVLF-FM before routine clinical deployment.”

Published in Nature Medicine · Current Stage: Real-World Cohort

AI in Medicine · Real-World Cohort
Study Type
Observational cohort study + Clinical AI evaluation

Observational cohort study + Clinical AI evaluation

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
Observational cohort study + Clinical AI evaluation in ai in medicine care
Intervention & Mechanism
A clinical multimodal vision language foundation model

AI model

Key Limitation
AI model accuracy depends on training dataset diversity and requires prospective validation across independent hospitals before routine rollout.

Translational Stage

LEVEL 2 · Real-World Cohort

Classified as Observational cohort study + Clinical AI evaluation along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Real-World CohortActive

Indexed Clinical Entities

Original Publication & AMA Citation

A clinical multimodal vision language foundation model with fine-grain explainability. Nature Medicine. Published 2026;Oct 29. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/42957777/

Nature Medicine

https://pubmed.ncbi.nlm.nih.gov/42957777/

Read Original Paper

Continue Reading

Related in AI in Medicine

View all AI in Medicine briefings →
AI in Medicine editorial photograph for ClinicalAge, a framework for modelling ageing trajectories from longitudinal electronic health records in the UK: a model development and validation study
AI IN MEDICINE · CLINICAL PRACTICE

ClinicalAge, a framework for modelling ageing trajectories from longitudinal electronic health records in the UK: a model development and validation study

Your Medical Records Could Reveal Your True 'Biological Age' — And Predict Your Health Future. A new AI tool, ClinicalAge, uses your existing health records to calculate your biological age, offering a powerful predictor of future health risks and lifespan.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readThe Lancet Digital Health
AI IN MEDICINE · CLINICAL PRACTICE

AI Enhances Bionic Vision Precision in Brain Implant Patient

An AI-powered system can precisely predict and generate personalized visual percepts in a blind individual with a brain implant by learning their unique cortical responses to electrical stimulation. Current bionic eye technologies, while offering some degree of visual perception, often struggle with precision, consistency, and the intuitive generation of meaningful visual information for the patient.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDaily
AI IN MEDICINE · PRECLINICAL

AI Discovers Natural Molecule for Obesity with Promising Side Effect Profile

AI-guided discovery of the natural molecule BRP offers a novel, potentially better-tolerated approach to obesity treatment than existing medications. BRP represents a potential 'Ozempic-like' treatment for obesity that may circumvent common digestive side effects and muscle loss often associated with current GLP-1 agonists.

2/5 Preclinical
Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readScienceDaily